Chongqing Zhifei Biological Products (300122.SZ): The monkeypox vaccine product in the pipeline is in the preclinical research stage.

Chongqing Zhifei Biological Products (300122.SZ) stated on an investor interaction platform on August 16 that the company's monkeypox vaccine product in the research pipeline is in the pre-clinical research stage.

Gelonghui FinanceAug 16 05:11 ET

As of August 9th, Chongqing Zhifei Biological Products (300122.SZ) had a total of 114002 ordinary shareholders.

Chongqing Zhifei Biological Products (300122.SZ) stated on the investor interaction platform on August 16th that as of August 9, 2024, the number of ordinary shareholders of the company was 114,002.

Gelonghui FinanceAug 16 05:10 ET

Chongqing Zhifei Biological Products (300122.SZ): Zhifei Longma withdrew its registration application for a quadrivalent split influenza virus vaccine (vials) and has been approved.

Chongqing Zhifei Biological Products (300122.SZ) announced that its wholly-owned subsidiary, Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. (...

Zhitong FinanceAug 15 07:29 ET

Chongqing Zhifei Biological Products (300122.SZ): Currently, there are 13 products listed and available for sale.

Chongqing Zhifei Biological Products (300122.SZ) stated on the investor interaction platform that the company currently has 13 products on the market, 1 product conditionally approved, including vaccines for infectious diseases such as meningococcal, cervical cancer, pneumonia, rotavirus, and herpes zoster, as well as drugs that provide effective solutions for the diagnosis, prevention, and treatment of tuberculosis infection, covering populations including infants, adolescents, and adults. At the same time, one product is in the stage of applying for marketing approval, two products have completed clinical trials, and six products are in phase III clinical trials. The company's extensive marketing network can enable

Gelonghui FinanceAug 9 05:31 ET

Is It Smart To Buy Chongqing Zhifei Biological Products Co., Ltd. (SZSE:300122) Before It Goes Ex-Dividend?

Simply Wall StAug 4 21:05 ET

Chongqing Zhifei Biological Products (300122.SZ) plans to distribute 8 yuan per 10 shares in 2023, with the ex-right and ex-dividend date on August 8th.

Chongqing Zhifei Biological Products (300122.SZ) announced that it plans to distribute cash to all shareholders in the year 2023, with a distribution ratio of 10 shares per shareholder...

Zhitong FinanceAug 1 08:37 ET